Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Behnaz Goudarzi"'
Publikováno v:
Environment Conservation Journal, Vol 16, Iss SE (2015)
Drilling operations, like any other industrial activity, at the end of the operation employed dumps waste, wastewater to the environment, and if there is no planning for treatment and their elimination, in long-term this can have adverse effects on t
Externí odkaz:
https://doaj.org/article/f6ef19a8703e41adbfdcf90f57657e3d
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 38:1908-1916
Regadenoson is a novel selective A2A adenosine receptor agonist, which is administered as an intravenous bolus at a fixed dose. It is currently not clear if the absolute flow increase in response to this fixed dose is a function of distribution volum
Publikováno v:
Academic Radiology. 17:1175-1185
Rationale and Objectives To determine if anatomically “nonmeasurable” disease in bone marrow (BM) is assessable for response to therapy by [18F]-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT). Materia
Autor:
Heather A. Jacene, Shingo Baba, Katarzyna J. Macura, Ihab R. Kamel, Behnaz Goudarzi, Oleg Teytelbaum, Daniel Chatzifotiadis, Sophie Leboulleux, Richard L. Wahl, Hua Ling Tsai, Jeanne Kowalski, Karen M. Horton
Publikováno v:
Journal of Nuclear Medicine. 50:1760-1769
Our goal was to estimate and compare across different readers the reproducibility of the (18)F-FDG PET standardized uptake value (SUV) and CT size measurements, and changes in those measurements, in malignant tumors before and after therapy.Fifty-two
Autor:
Paco E, Bravo, Behnaz, Goudarzi, Uzma, Rana, Paulo Togni, Filho, Raymond, Castillo, Christopher, Rababy, Marjorie, Ewertz, Harvey A, Ziessman, David S, Cooper, Paul W, Ladenson, Richard L, Wahl
Publikováno v:
International journal of clinical and experimental medicine. 6(5)
Radioactive therapy with (131)I (RAI) is commonly used during the management of patients with differentiated thyroid cancer (DTC). The aim of this study was to determine the clinical significance of discordant findings between pre-RAI whole body scan
Publikováno v:
Academic radiology. 17(9)
To determine if anatomically "nonmeasurable" disease in bone marrow (BM) is assessable for response to therapy by [(18)F]-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT).FDG PET/CT images of 27 patients wi
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49(10)
UNLABELLED: (18)F-FDG PET has been reported to have reduced sensitivity in detecting bronchioloalveolar carcinoma (BAC) versus lung cancers with other histologies. However, there are CT characteristics that are suggestive of BAC, and potentially thes
Publikováno v:
European journal of nuclear medicine and molecular imaging. 35(1)
To describe increased 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) uptake in the scalene muscles in a large population of patients referred for evaluation with FDG positron emission tomography/computed tomography (PET/CT) imaging.The study met criteria f